| scholarly article | Q13442814 |
| P50 | author | Tacjana Pressler | Q114439126 |
| Henrik Enghusen Poulsen | Q33310622 | ||
| Oana Ciofu | Q40705960 | ||
| Niels Høiby | Q12328808 | ||
| P2093 | author name string | Bente Riis | |
| P2860 | cites work | High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 |
| The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. | Q44615245 | ||
| Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation | Q44916257 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. | Q47946251 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli | Q49201462 | ||
| Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. | Q50557315 | ||
| Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). | Q50564526 | ||
| Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q67990758 | ||
| Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function | Q68273128 | ||
| Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs | Q68354486 | ||
| N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility | Q69506423 | ||
| Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes | Q71578669 | ||
| Evidence for increased oxidative damage in patients with cystic fibrosis | Q72397235 | ||
| Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis | Q78010335 | ||
| MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis | Q28343030 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Characterization of the GO system of Pseudomonas aeruginosa | Q28492940 | ||
| The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) | Q29619959 | ||
| Evolution-driving genes | Q33949870 | ||
| Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review | Q33975684 | ||
| Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. | Q33986675 | ||
| Direct selection for mutators in Escherichia coli. | Q33991388 | ||
| 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity | Q34119141 | ||
| Escherichia coli mutY gene encodes an adenine glycosylase active on G-A mispairs | Q34319463 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA | Q37132610 | ||
| Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains | Q37421041 | ||
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
| Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis | Q39468249 | ||
| Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms | Q40155064 | ||
| Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. | Q40230334 | ||
| Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics | Q40673380 | ||
| Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains | Q41201457 | ||
| Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease | Q41354550 | ||
| Pulmonary oxidative stress response in young children with cystic fibrosis | Q42152011 | ||
| Oxidative stress in cystic fibrosis: dietary and metabolic factors. | Q43605406 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| inflammation | Q101991 | ||
| cystic fibrosis | Q178194 | ||
| patient | Q181600 | ||
| P304 | page(s) | 2276-2282 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | |
| P478 | volume | 49 |
| Q42656960 | A single point mutation in class III ribonucleotide reductase promoter renders Pseudomonas aeruginosa PAO1 inefficient for anaerobic growth and infection. |
| Q51489925 | A trade-off between oxidative stress resistance and DNA repair plays a role in the evolution of elevated mutation rates in bacteria. |
| Q93270599 | Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations |
| Q36580765 | Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa |
| Q41937031 | Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. |
| Q40920555 | Antioxidant Hydroxytyrosol-Based Polyacrylate with Antimicrobial and Antiadhesive Activity Versus Staphylococcus Epidermidis. |
| Q38147863 | Applying insights from biofilm biology to drug development - can a new approach be developed? |
| Q36933558 | Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa |
| Q43264873 | Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa |
| Q43153453 | Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants |
| Q27334684 | Bacterial evolution in PCD and CF patients follows the same mutational steps |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q38012391 | Bacterial stress responses as determinants of antimicrobial resistance |
| Q34953383 | Breaking the rules: bacteria that use several DNA polymerase IIIs |
| Q38815266 | CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response |
| Q39696154 | Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection |
| Q38207078 | Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q34948367 | Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. |
| Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
| Q53802828 | Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009. |
| Q39097378 | Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis |
| Q42043676 | Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. |
| Q31029779 | Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. |
| Q53173700 | Effect of organic matter on the in vitro photoeradication of Pseudomonas aeruginosa by means of a cationic tetraaryl-porphyrin. |
| Q34509793 | Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa |
| Q34003782 | Efflux pumps as antimicrobial resistance mechanisms |
| Q46608208 | Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy |
| Q33886303 | Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage |
| Q29346762 | Epoxide-mediated CifR repression of cif gene expression utilizes two binding sites in Pseudomonas aeruginosa. |
| Q34082906 | Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. |
| Q28238561 | Evolution of mutation rates in bacteria |
| Q33911762 | Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone |
| Q34937408 | Evolutionary dynamics of bacteria in a human host environment |
| Q38417030 | Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q41903957 | Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients |
| Q55299552 | Gender differences in bronchiectasis: a real issue? |
| Q41366386 | Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation |
| Q28536866 | Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators |
| Q33424246 | Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa |
| Q30278439 | Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains |
| Q51732418 | Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. |
| Q51711564 | High relatedness selects against hypermutability in bacterial metapopulations. |
| Q36667671 | Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities. |
| Q44350722 | Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance |
| Q58098483 | Hypermutation-induced in vivo oxidative stress resistance enhances Vibrio cholerae host adaptation |
| Q89766030 | Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients |
| Q42560500 | Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. |
| Q42909082 | Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections. |
| Q35879111 | Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. |
| Q37510338 | Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients |
| Q38962871 | Involvement of stress-related genes polB and PA14_46880 in biofilm formation of Pseudomonas aeruginosa |
| Q91899313 | Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms |
| Q57166411 | Long-Term Colonization Dynamics of Enterococcus faecalis in Implanted Devices in Research Macaques |
| Q40480159 | Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates. |
| Q34155281 | Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells. |
| Q51173006 | Microbial ecology and adaptation in cystic fibrosis airways. |
| Q34117477 | Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections |
| Q33355731 | Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa |
| Q37413900 | Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis |
| Q37319878 | Nutrient reduction induced stringent responses promote bacterial quorum-sensing divergence for population fitness |
| Q33977944 | Overexpression of CupB5 activates alginate overproduction in Pseudomonas aeruginosa by a novel AlgW-dependent mechanism |
| Q37719105 | Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections. |
| Q41841534 | Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa |
| Q38309969 | PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. |
| Q38006032 | Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections |
| Q81299848 | Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q36305614 | Phosphorothioate DNA as an antioxidant in bacteria |
| Q34179233 | Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes |
| Q42910111 | Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa |
| Q35006748 | Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis |
| Q35975439 | Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator |
| Q38273318 | Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. |
| Q33522442 | Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. |
| Q38268531 | Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. |
| Q28299966 | Pseudomonas aeruginosa biofilms in cystic fibrosis |
| Q33559774 | Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients |
| Q37589273 | Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation. |
| Q37947373 | Resistance of bacterial biofilms to disinfectants: a review. |
| Q47148244 | Revision of the joint AFC/BIOHAZ guidance document on the submission of data for the evaluation of the safety and efficacy of substances for the removal of microbial surface contamination of foods of animal origin intended for human consumption |
| Q33482815 | Role of mutation in Pseudomonas aeruginosa biofilm development. |
| Q59139141 | Silver against Pseudomonas aeruginosa biofilms |
| Q34693898 | Social cheating in Pseudomonas aeruginosa quorum sensing |
| Q38267242 | Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more |
| Q42572942 | Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa |
| Q35244339 | Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis. |
| Q35695892 | Synthesis and structure-activity relationships of novel cationic lipids with anti-inflammatory and antimicrobial activities. |
| Q37866284 | Targeting airway inflammation in cystic fibrosis in children: past, present, and future |
| Q91623019 | The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress |
| Q40324438 | The GO system prevents ROS-induced mutagenesis and killing in Pseudomonas aeruginosa |
| Q35746213 | The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice |
| Q39174238 | The antioxidant resveratrol down-regulates inflammation in an in-vitro model of Pseudomonas aeruginosa infection of lung epithelial cells |
| Q64056369 | The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity |
| Q38130513 | The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection. |
| Q38300820 | The problems of antibiotic resistance in cystic fibrosis and solutions |
| Q35885995 | The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa |
| Q102053771 | The sino-nasal warzone: transcriptomic and genomic studies on sino-nasal aspergillosis in dogs |
| Q38898519 | The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates |
| Q37206311 | What makes pathogens pathogenic |
| Q35813781 | Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients |
| Q28533745 | nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa |
Search more.